This study is looking at whether a device called the DyeVert Plus System can help prevent acute kidney injury (AKI) in people at high risk who are having heart procedures like coronary angiography (CAG) or percutaneous coronary intervention (PCI). These procedures sometimes use a special dye that can affect the kidneys. The DyeVert Plus System helps doctors monitor and limit the amount of dye used. Participants will also receive a standardized hydration protocol, similar to the Poseidon protocol. Researchers will check for AKI at 3 days to see if the DyeVert Plus System makes a difference. You may be able to join if you are 18 or older, are scheduled for CAG or PCI, have certain kidney function levels (eGFR between 20 and 60 mL/min/1.73 m2, and serum creatinine over 1.5 mg/dl), and have high blood pressure or diabetes. The current recruitment status is unclear.

Study design

This is an interventional study planning to enroll 1802 participants. It is a single-center prospective study, meaning all participants are at one location and followed forward in time.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be monitored for acute kidney injury (AKI) at 3 days after the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.